Artykuły w czasopismach na temat „Pancancer”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Pancancer”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Wong, Chi Chun, i Jun Yu. "Mapping the pancancer metastasis tumor microbiome". Cell 187, nr 9 (kwiecień 2024): 2126–28. http://dx.doi.org/10.1016/j.cell.2024.03.040.
Pełny tekst źródłaKappmeier, Claudia, Sherina Edward, Corinna Hochstein, Ellen Inga Bruske, Francesca Di Pasquale i Ronny Kellner. "Abstract 1470: Advancing cancer research: A novel PanCancer digital PCR tool for simultaneous detection of multiple hallmark mutations in BRAF and EGFR". Cancer Research 84, nr 6_Supplement (22.03.2024): 1470. http://dx.doi.org/10.1158/1538-7445.am2024-1470.
Pełny tekst źródłaLi, Fei, Jing Chen, Xiaoyan Zhang, Dongxiao Yang, Liang Xia, Dazhong Wang, Kai Jin i in. "Characterization of MET exon 14 skipping in pancancer." Journal of Clinical Oncology 40, nr 16_suppl (1.06.2022): e20530-e20530. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.e20530.
Pełny tekst źródłaCheerla, Anika, i Olivier Gevaert. "Deep learning with multimodal representation for pancancer prognosis prediction". Bioinformatics 35, nr 14 (lipiec 2019): i446—i454. http://dx.doi.org/10.1093/bioinformatics/btz342.
Pełny tekst źródłaLiu, Kui, Jing Ma, Jiao Ao, Lili Mu, Yixian Wang, Yue Qian, Jin Xue i Wei Zhang. "The Oncogenic Role and Immune Infiltration for CARM1 Identified by Pancancer Analysis". Journal of Oncology 2021 (27.10.2021): 1–15. http://dx.doi.org/10.1155/2021/2986444.
Pełny tekst źródłaJiang, Aimin, Ye Zhou, Wenliang Gong, Xin Pan, Xinxin Gan, Zhenjie Wu, Bing Liu, Le Qu i Linhui Wang. "CCNA2 as an Immunological Biomarker Encompassing Tumor Microenvironment and Therapeutic Response in Multiple Cancer Types". Oxidative Medicine and Cellular Longevity 2022 (31.03.2022): 1–35. http://dx.doi.org/10.1155/2022/5910575.
Pełny tekst źródłaKarpova, Alla, Nadezhda V. Terekhanova, Siqi Chen, Reyka G. Jayasinghe, Andrew Houston, Wagma Caravan, Ryan C. Fields i Li Ding. "Abstract 2627: PanCancer epigenetic regulators of lymphocyte activation states". Cancer Research 84, nr 6_Supplement (22.03.2024): 2627. http://dx.doi.org/10.1158/1538-7445.am2024-2627.
Pełny tekst źródłaJi, Haizhou, Mi Ren, Tongyu Liu i Yang Sun. "Prognostic and Immunological Significance of CXCR2 in Ovarian Cancer: A Promising Target for Survival Outcome and Immunotherapeutic Response Assessment". Disease Markers 2021 (19.11.2021): 1–21. http://dx.doi.org/10.1155/2021/5350232.
Pełny tekst źródłaCooper, Lee AD, Elizabeth G. Demicco, Joel H. Saltz, Reid T. Powell, Arvind Rao i Alexander J. Lazar. "PanCancer insights from The Cancer Genome Atlas: the pathologist's perspective". Journal of Pathology 244, nr 5 (22.02.2018): 512–24. http://dx.doi.org/10.1002/path.5028.
Pełny tekst źródłaNorton, John T., Callie B. Pollock, Chen Wang, Julian C. Schink, J. Julie Kim i Sui Huang. "Perinucleolar compartment prevalence is a phenotypic pancancer marker of malignancy". Cancer 113, nr 4 (15.08.2008): 861–69. http://dx.doi.org/10.1002/cncr.23632.
Pełny tekst źródłaChen, Hao, Fan Xu, Anqi Qin, Shuai Guo, Ge Zhang, Bo Yu i Quanhui Zheng. "A pancancer analysis of histone deacetylase 3 in human tumors". Translational Cancer Research 13, nr 1 (styczeń 2024): 65–80. http://dx.doi.org/10.21037/tcr-23-1228.
Pełny tekst źródłaYu, Xiaoqing, Song Li, Ling Cen i Xuefeng Wang. "Abstract 3557: A pancancer gamma delta T cell repertoire atlas". Cancer Research 84, nr 6_Supplement (22.03.2024): 3557. http://dx.doi.org/10.1158/1538-7445.am2024-3557.
Pełny tekst źródłaWu, Yunhui, Jingying Zhang, Can Hou, Hongyu Wang, Min Zhu i Xin Yao. "A Pancancer Study of PIEZO1 as a Prognosis and Immune Biomarker of Human Tumors". Journal of Oncology 2022 (14.06.2022): 1–15. http://dx.doi.org/10.1155/2022/6725570.
Pełny tekst źródłaPeng, Ge, Saya Tsukamoto, Ko Okumura, Hideoki Ogawa, Shigaku Ikeda i François Niyonsaba. "A Pancancer Analysis of the Oncogenic Role of S100 Calcium Binding Protein A7 (S100A7) in Human Tumors". Biology 11, nr 2 (11.02.2022): 284. http://dx.doi.org/10.3390/biology11020284.
Pełny tekst źródłaAharonov, Ranit, Gal Dinstag, Eldad Shulman, Efrat Elis, Doreen Ben-Zvi, Omer Tirosh, Danh-Tai Hoang i in. "ENLIGHT: Pancancer response prediction to targeted and immunotherapies via tumor transcriptomics." Journal of Clinical Oncology 40, nr 16_suppl (1.06.2022): e13556-e13556. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.e13556.
Pełny tekst źródłaAharonov, Ranit, Gal Dinstag, Eldad Shulman, Efrat Elis, Doreen Ben-Zvi, Omer Tirosh, Danh-Tai Hoang i in. "ENLIGHT: Pancancer response prediction to targeted and immunotherapies via tumor transcriptomics." Journal of Clinical Oncology 40, nr 16_suppl (1.06.2022): e13556-e13556. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.e13556.
Pełny tekst źródłaSwami, Nishwant, Edward Christopher Dee, Brandon A. Mahal, Fumiko Chino i Narjust Duma. "Financial toxicity in Hispanic cancer survivors: A nationally representative pancancer analysis." Journal of Clinical Oncology 40, nr 16_suppl (1.06.2022): 6528. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.6528.
Pełny tekst źródłaCui, Jing, Yongjie Tian, Tianhang Liu, Xueyan Lin, Lanyu Li, Zhonghui Li i Liang Shen. "Pancancer Analysis of Revealed TDO2 as a Biomarker of Prognosis and Immunotherapy". Disease Markers 2022 (9.09.2022): 1–18. http://dx.doi.org/10.1155/2022/5447017.
Pełny tekst źródłaWu, Changwu, Yingjuan Duan, Siming Gong, Sonja Kallendrusch, Nikolas Schopow i Georg Osterhoff. "Integrative and Comprehensive Pancancer Analysis of Regulator of Chromatin Condensation 1 (RCC1)". International Journal of Molecular Sciences 22, nr 14 (9.07.2021): 7374. http://dx.doi.org/10.3390/ijms22147374.
Pełny tekst źródłaYang, Jing, Xiaojing Liu, Yueqin Shao, Hong Zhou, Lijun Pang i Wei Zhu. "Diagnostic, Prognostic, and Immunological Roles of FABP4 in Pancancer: A Bioinformatics Analysis". Computational and Mathematical Methods in Medicine 2022 (8.12.2022): 1–19. http://dx.doi.org/10.1155/2022/3764914.
Pełny tekst źródłaFox, Eleonore, Guillaume Appe, Abdelkader Behdenna, Lea Meunier, Akpeli Nordor, Solene Weill i Camille Marijon. "Abstract 1915: A scalable pancancer antigen target discovery platform for precision oncology". Cancer Research 84, nr 6_Supplement (22.03.2024): 1915. http://dx.doi.org/10.1158/1538-7445.am2024-1915.
Pełny tekst źródłaYe, Tao, Lan-lan Li, Xue-mei Peng i Qin Li. "CYP1B1-AS1 Is a Novel Biomarker in Glioblastoma by Comprehensive Analysis". Disease Markers 2021 (29.12.2021): 1–8. http://dx.doi.org/10.1155/2021/8565943.
Pełny tekst źródłaNguyen, Phuong Thao, Yudai Shimojukkoku, Yuka Kajiya, Yasunobu Oku, Ayami Tomishima, Kaori Shima i Tomonori Sasahira. "Gene alterations in the nuclear transport receptor superfamily: A study of head and neck cancer". PLOS ONE 19, nr 5 (31.05.2024): e0300446. http://dx.doi.org/10.1371/journal.pone.0300446.
Pełny tekst źródłaLin, Xin, Min Xiao, Zhitao Chen, Chenchen Ding, Ting Zhang i Qiyong Li. "Pancancer Analyses Reveal Genomics and Clinical Characteristics of the SETDB1 in Human Tumors". Journal of Oncology 2022 (23.05.2022): 1–40. http://dx.doi.org/10.1155/2022/6115878.
Pełny tekst źródłaZhou, Yiyi, Shuangshuang Xu, Qinying Sun i Yuchao Dong. "An Analysis of BMP1 Associated with m6A Modification and Immune Infiltration in Pancancer". Disease Markers 2022 (11.10.2022): 1–28. http://dx.doi.org/10.1155/2022/7899961.
Pełny tekst źródłaOu, Qiyun, Yunfang Yu, Haitao Zhong, Anlin Li, Yongjian Chen, HaiYu Zhou, Shaopeng Zheng, Luyu Huang i Herui Yao. "Association of immune-related adverse events with immune checkpoint inhibitor efficacy in pancancer." Journal of Clinical Oncology 37, nr 15_suppl (20.05.2019): e14087-e14087. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.e14087.
Pełny tekst źródłaLiu, Ranran, Tianyu Li, Guohong Zhang, Yejuan Jia, Jingxuan Liu, Lijia Pan, Yunfeng Li i Chunsheng Jia. "Pancancer Analysis Revealed the Value of RAC2 in Immunotherapy and Cancer Stem Cell". Stem Cells International 2023 (12.05.2023): 1–17. http://dx.doi.org/10.1155/2023/8485726.
Pełny tekst źródłaNiederhausern, Andrew, Nadia S. Bahadur, Gary Wallace, Gilan E. Saadawi i John Philip. "Abstract 4966: Machine learning and large language model approach to pancancer data elements". Cancer Research 84, nr 6_Supplement (22.03.2024): 4966. http://dx.doi.org/10.1158/1538-7445.am2024-4966.
Pełny tekst źródłaGong, Xiaoming, Tao Chen, Cheyu Lin, Haiqin Ping, Xin Tong, Kai Zhang, Zhaojun Chen, Caiyun Cai, Zhiyan Lu i Hengning Ke. "Bioinformatics Analysis of the Prognostic Significance of VPS16 in Hepatocellular Carcinoma and Its Role in Drug Screening". BioMed Research International 2023 (17.04.2023): 1–13. http://dx.doi.org/10.1155/2023/2501596.
Pełny tekst źródłaWu, Zixuan, Yanhui Jiang, Xuyan Huang, Minjie Cai, Kai Yuan, Peidong Huang i Zuhong Wang. "In the Tumor Microenvironment, ETS1 Is an Oncogenic Immune Protein: An Integrative Pancancer Analysis". Evidence-Based Complementary and Alternative Medicine 2022 (15.04.2022): 1–12. http://dx.doi.org/10.1155/2022/7730433.
Pełny tekst źródłaYang, Ziyue, Yuanyuan Zhu, Zhenfen Li, Zhangya Pu, Ying Lin, Ying Deng, Ning Li i Fang Peng. "Pancancer Analysis of the Prognostic and Immunotherapeutic Value of Progestin and AdipoQ Receptor 4". Computational and Mathematical Methods in Medicine 2022 (17.12.2022): 1–24. http://dx.doi.org/10.1155/2022/2528164.
Pełny tekst źródłaLiu, Qiaojun, Renjian Xie i Yumei Li. "Pancancer Analysis of the Oncogenic and Prognostic Role of NOL7: A Potential Target for Carcinogenesis and Survival". International Journal of Molecular Sciences 23, nr 17 (25.08.2022): 9611. http://dx.doi.org/10.3390/ijms23179611.
Pełny tekst źródłaEl-Deiry, Wafik S., Taylor Arnoff, Ilyas Sahin, Hossein Borghaei, Vivek Subbiah, Hina Khan, Benedito A. Carneiro i in. "A pancancer analysis of impact of MDM2/MDM4 on immune checkpoint blockade (ICB)." Journal of Clinical Oncology 40, nr 16_suppl (1.06.2022): 2630. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.2630.
Pełny tekst źródłaDouglass, Eugene F., Robert J. Allaway, Bence Szalai, Wenyu Wang, Tingzhong Tian, Adrià Fernández-Torras, Ron Realubit i in. "A community challenge for a pancancer drug mechanism of action inference from perturbational profile data". Cell Reports Medicine 3, nr 1 (styczeń 2022): 100492. http://dx.doi.org/10.1016/j.xcrm.2021.100492.
Pełny tekst źródłaGao, Chao, Xiangqin Fan, Yanyan Liu, Yanyan Han, Shiqi Liu, Huanrong Li, Qiaoling Zhang, Yingmei Wang i Fengxia Xue. "Comprehensive Analysis Reveals the Potential Roles of CDKN3 in Pancancer and Verification in Endometrial Cancer". International Journal of General Medicine Volume 16 (grudzień 2023): 5817–39. http://dx.doi.org/10.2147/ijgm.s438479.
Pełny tekst źródłaLu, Jianyun, Jasmin Sponagel, Jill Jones, Hannah Gass, Elena Nunez, Cheryl Frankfater, Sierra Williams-McLeod i in. "TMET-13. SEX DIFFERENCES IN GLUCOSE METABOLISM AND MITOCHONDRIAL FUNCTION IN GLIOBLASTOMA IMPLICATE HYPOXIA-INDUCIBLE FACTOR 1 ALPHA (HIF1A) ACTIVITY". Neuro-Oncology 24, Supplement_7 (1.11.2022): vii264. http://dx.doi.org/10.1093/neuonc/noac209.1018.
Pełny tekst źródłaDeng, Chao, Hang Guo, Dongliang Yan, Tao Liang, Xuxiao Ye i Zuowei Li. "Pancancer Analysis of Neurovascular-Related NRP Family Genes as Potential Prognostic Biomarkers of Bladder Urothelial Carcinoma". BioMed Research International 2021 (15.04.2021): 1–31. http://dx.doi.org/10.1155/2021/5546612.
Pełny tekst źródłaMiyashita, Hirotaka, Nicholas J. Bevins, Kartheeswaran Thangathurai, Suzanna Lee, Sarabjot Pabla, Mary Nesline, Sean Glenn i in. "Comprehensive transcriptomic analysis of immune checkpoint markers in a pancancer cohort: Implications for response and resistance." Journal of Clinical Oncology 40, nr 16_suppl (1.06.2022): 2555. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.2555.
Pełny tekst źródłaNiavarani, Ahmadreza, Asieh Shahrabi Farahani, Maryam Sharafkhah i Minoo Rassoulzadegan. "Pancancer analysis identifies prognostic high-APOBEC1 expression level implicated in cancer in-frame insertions and deletions". Carcinogenesis 39, nr 3 (13.01.2018): 327–35. http://dx.doi.org/10.1093/carcin/bgy005.
Pełny tekst źródłaArigbede, Olumide, Sarah G. Buxbaum, Sara Falzarano i Suhn Rhie. "Abstract A078: Exploration, analysis and visualization of TCGA pancancer data in the cBioPortal: Prostate adenocarcinoma genomics". Cancer Epidemiology, Biomarkers & Prevention 32, nr 1_Supplement (1.01.2023): A078. http://dx.doi.org/10.1158/1538-7755.disp22-a078.
Pełny tekst źródłaChampion, Magali, Kevin Brennan, Tom Croonenborghs, Andrew J. Gentles, Nathalie Pochet i Olivier Gevaert. "Module Analysis Captures Pancancer Genetically and Epigenetically Deregulated Cancer Driver Genes for Smoking and Antiviral Response". EBioMedicine 27 (styczeń 2018): 156–66. http://dx.doi.org/10.1016/j.ebiom.2017.11.028.
Pełny tekst źródłaReckamp, Karen L., Jasmine A. McQuerry, Isa Mambetsariev, Rebecca Pharaon, Susan E. Yost, Jeremy Fricke, Tamara Mirzapoiazova i in. "Co-stimulatory and co-inhibitory immune markers in solid tumors with MET alterations". Future Science OA 7, nr 2 (luty 2021): FSO662. http://dx.doi.org/10.2144/fsoa-2020-0159.
Pełny tekst źródłaWu, Zixuan, Dongli Jiang, Xuyan Huang, Minjie Cai, Kai Yuan i Peidong Huang. "S100A8 as a Promising Biomarker and Oncogenic Immune Protein in the Tumor Microenvironment: An Integrative Pancancer Analysis". Journal of Oncology 2022 (18.03.2022): 1–15. http://dx.doi.org/10.1155/2022/6947652.
Pełny tekst źródłaWu, Yumeng, Xuming Wu, Yuanyuan Li, Wenjing Zhao, Yanping Yue, Biao Wu, Jibin Liu, Xudong Chen i Aiguo Shen. "Comprehensive Analysis of Glutamate-Rich WD Repeat-Containing Protein 1 and Its Potential Clinical Significance for Pancancer". BioMed Research International 2021 (27.09.2021): 1–16. http://dx.doi.org/10.1155/2021/8201377.
Pełny tekst źródłaLi, Xuanyi, Ben Ho Park, Justin M. Balko i Douglas Buckner Johnson. "Pathway enrichment analysis in tumors with high mutation burdens and interferon-γ signature expression: A pancancer analysis." Journal of Clinical Oncology 41, nr 16_suppl (1.06.2023): 3138. http://dx.doi.org/10.1200/jco.2023.41.16_suppl.3138.
Pełny tekst źródłaXu, Yining, Xinran Cui, Liyuan Zhang, Tianyi Zhao i Yadong Wang. "Metastasis-related gene identification by compound constrained NMF and a semisupervised cluster approach using pancancer multiomics features". Computers in Biology and Medicine 151 (grudzień 2022): 106263. http://dx.doi.org/10.1016/j.compbiomed.2022.106263.
Pełny tekst źródłaDeng, Hui, Hanming Yao, Shurui Zhou, Chong He, Yuzhou Huang, Yunlong Li, Hanwei Chen i Jianchang Shu. "Pancancer analysis uncovers an immunological role and prognostic value of the m6A reader IGF2BP2 in pancreatic cancer". Molecular and Cellular Probes 73 (luty 2024): 101948. http://dx.doi.org/10.1016/j.mcp.2023.101948.
Pełny tekst źródłaHuang, Juntao, Ziqian Xu, Dahua Chen, Chongchang Zhou i Yi Shen. "Pancancer analysis reveals the role of disulfidptosis in predicting prognosis, immune infiltration and immunotherapy response in tumors". Medicine 102, nr 52 (29.12.2023): e36830. http://dx.doi.org/10.1097/md.0000000000036830.
Pełny tekst źródłaInternational, BioMed Research. "Retracted: Pancancer Analysis of Neurovascular-Related NRP Family Genes as Potential Prognostic Biomarkers of Bladder Urothelial Carcinoma". BioMed Research International 2024 (20.03.2024): 1. http://dx.doi.org/10.1155/2024/9802197.
Pełny tekst źródłaLeivonen, Suvi-Katri, Judit Jørgensen, Thomas Stauffer Larsen, Annika Pasanen, Marja-Liisa Karjalainen-Lindsberg, Helle M. Toldbod, Francesco d'Amore i Sirpa Leppa. "Molecular Profiling of Aggressive Non-Hodgkin Lymphoma - Results from a Phase 1/2 Preben Study". Blood 134, Supplement_1 (13.11.2019): 5314. http://dx.doi.org/10.1182/blood-2019-129113.
Pełny tekst źródła